Expertise Across Every Phase of Your Trial Journey.

Hope in Every Treatment, Strength in Every Step.

Clinical trials are the cornerstone of bringing innovative treatments and therapies to life. At Conduct Research, we offer end-to-end support across all clinical trial phases (I-IV), ensuring your research progresses seamlessly from concept to market.

 

Each phase presents unique challenges and opportunities, and our expertise guarantees precision, compliance, and efficiency at every step.

 

We understand that no two clinical trials are the same. Whether you’re embarking on early-stage testing or conducting large-scale, post-market surveillance, our team delivers tailored solutions to meet the specific needs of your trial. Partnering with us ensures that your study is equipped with the expertise, tools, and strategies necessary to achieve impactful outcomes.

Phase Level Support

Phase I : Early-Phase Testing

  1. Focus: Safety and dosage determination in healthy volunteers or patients.
  2. Services:
    • Recruitment and retention of participants.
    • Dose-escalation studies to determine safety margins.
    • Intensive pharmacokinetic and pharmacodynamic monitoring.
  3. Deliverables: Comprehensive safety profiles and robust data for advancing to the next phase.

Phase II : Efficacy in Targeted Populations

  1. Focus: Establishing the treatment’s efficacy while continuing safety assessments.
  2. Services:
    • Patient population selection aligned with the therapeutic area (e.g., oncology).
    • Endpoint definition and mid-study adjustments for better precision.
    • Data management systems for accurate and timely reporting.
  3. Deliverables: Proof-of-concept data that highlights therapeutic potential.

Phase III : Large-Scale Trials for Regulatory Approvals

  1. Focus: Confirming efficacy and safety in larger, diverse populations.
  2. Services:
    • Coordination across multiple sites and countries.
    • Development of regulatory-compliant clinical trial reports for submissions (e.g., FDA, EMA).
    • Real-time monitoring tools for site performance and risk mitigation.
  3. Deliverables: High-quality data that forms the basis of regulatory approval.

Phase IV : Post-Market Surveillance

  1. Focus: Monitoring long-term safety, efficacy, and market performance.
  2. Services:
    • Designing and conducting real-world evidence (RWE) studies.
    • Tracking adverse events to ensure ongoing patient safety.
    • Generating insights to support marketing claims and product optimization.
  3. Deliverables: Reports on real-world safety and efficacy that maintain trust and compliance.

Ready to accelerate your clinical trial journey?

Contact us today to explore our comprehensive phase support solutions!